News

Cobenfy (xanomeline and trospium chloride) as an adjunctive treatment to atypical antipsychotics demonstrated a 2.0-point ...
VivaVision Biotech reveals promising phase 2 trial results for VVN461, a new treatment for Non-Infectious Anterior Uveitis, ...
The FDA cleared the launch of a Phase 1 clinical trial to test cell therapy XS-228 in people with amyotrophic lateral ...
Statistically significant improvements observed across clinical endpoints; final cohort results expected in Q2 2025 ...
Data from the BroADen Phase 1b atopic dermatitis (AD) patient trial expected to be reported in 4Q25 Completed SAD/MAD dosing in KT-621 Phase 1 healthy volunteer trial with data to be reported in June ...
New targeted delivery technology offers hope for aggressive brain cancer treatment.
Phase 1 trial of TGW101 in advanced solid tumors is enrolling to assess safety and pharmacokinetics and define the maximum ...
Abstract Title: Preliminary results from the randomized phase 2 study (1801 part 3B) of elraglusib in combination with ...
Scale-up is a common problem encountered in all forms of development across industries, and oral solid dose manufacturing ...
This came after the firm presented their proposal for the manufacturing and marketing of Roflumilast Cream 0.3% w/w for the ...